イムノアッセイの世界市場予測：試薬、キット、分析器、ソフトウェア、サービス...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 33)
4.1 The Immunoassay Market is Projected to Grow at A Robust Growth Rate From 2016 to 2021
4.2 Geographic Analysis: Global Immunoassay Market, By Product and Service
4.3 Global Immunoassay Market, By Technology
4.4 Geographical Snapshot of the Global Market
4.5 Global Market, By Application
4.6 Global Market, By End User
4.7 Lifecycle Analysis, By Region

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Immunoassay Market: Drivers, Restraints, Opportunities, and Challenges
5.2.2 Drivers
5.2.2.1 Growing Prevalence of Infectious and Chronic Diseases
5.2.2.2 Extensive Use of Immunoassay in Oncology
5.2.2.3 Technological Advancements
5.2.2.4 Cost-Effectiveness & Rapid Analysis
5.2.2.5 Growth in the Biotechnology and Pharmaceutical Sector
5.2.3 Restraints
5.2.3.1 Low Detection Limit of Immunoassay
5.2.3.2 Implementation of Excise Duty By the U.S. Government
5.2.3.3 Stringent Regulations
5.2.4 Opportunities
5.2.4.1 Integration of Microfluidics in Immunoassay
5.2.4.2 Point-Of-Care Testing With Multiplex Assay
5.2.4.3 Emerging Economies
5.2.5 Challenges
5.2.5.1 Pricing Pressure on Manufacturers

6 Immunoassay Market, By Technology (Page No. – 46)
6.1 Introduction
6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
6.2.1 ELISA Market, By Platform
6.2.1.1 Chemiluminescence Immunoassay (CLIA)
6.2.1.2 Fluorescence Immunoassay (FIA)
6.2.1.3 Colorimetric Immunoassay (CI)
6.2.2 ELISA Market, By Type
6.2.2.1 First Generation
6.2.2.2 Second Generation
6.2.2.3 Third Generation
6.2.2.4 Fourth Generation and Above
6.3 Rapid Tests
6.4 Western Blot
6.5 Elispot
6.6 Radioimmunoassay (RIA)
6.7 Polymerase Chain Reaction (PCR)

7 Immunoassay Market, By Product and Service (Page No. – 63)
7.1 Introduction
7.2 Reagents & Kits
7.2.1 By Type
7.2.1.1 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents and Kits
7.2.1.2 Rapid Test Reagents and Kits
7.2.1.3 Western Blot Reagents and Kits
7.2.1.4 Elispot Reagents and Kits
7.2.1.5 RIA Reagents and Kits
7.2.1.6 PCR Reagents and Kits
7.3 Analyzers
7.3.1 By Purchase Mode
7.3.1.1 Reagent Rental Purchase
7.3.1.2 Outright Purchase
7.3.2 By Type
7.3.2.1 Open-Ended Systems
7.3.2.2 Closed-Ended Systems
7.4 Software and Services

8 Immunoassay Market, By Application (Page No. – 81)
8.1 Introduction
8.2 Infectious Diseases
8.3 Endocrinology
8.4 Bone and Mineral Disorders
8.5 Oncology
8.6 Cardiology
8.7 Hematology and Blood Screening
8.8 Autoimmune Disorders
8.9 Toxicology
8.10 Neonatal Screening
8.11 Other Applications

9 Immunoassay Market, By End User (Page No. – 98)
9.1 Introduction
9.2 Hospitals
9.3 Clinical Laboratories
9.4 Blood Banks
9.5 Research & Academic Laboratories
9.6 Pharmaceutical Companies, Cros, and Biotechnology Companies
9.7 Other End Users

10 Immunoassay Market, By Region (Page No. – 108)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 South Korea
10.4.5 Taiwan
10.4.6 Rest of Asia (RoA)
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 164)
11.1 Introduction
11.2 Strategic Overview
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Agreements, Partnerships, and Collaborations
11.4.2 Regulatory Approvals
11.4.3 Expansions
11.4.4 Product Launches
11.4.5 Acquisitions

12 Company Profiles (Page No. – 172)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 F. Hoffmann-La Roche Ltd.
12.3 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
12.4 Bio-Rad Laboratories, Inc.
12.5 Siemens AG
12.6 Sysmex Corporation
12.7 Biomérieux Sa
12.8 Alere Inc.
12.9 Becton, Dickinson and Company
12.10 Ortho Clinical Diagnostics, Inc.
12.11 Abbott Laboratories, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 196)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports